top of page
Less than 15% of drugs that enter clinical trials ever reach the market. $170B a year is spent on drugs that never make it to the patient.*
meet emme connect™—a dynamic, AI-powered strategic platform that streamlines drug development by aligning insight, equity, and execution. From early pipeline to post-launch, emme connect de-risks your path with real-time intelligence, human-centered design, and system-aware strategy—so your innovation doesn't just survive the journey, it changes lives at scale.
Bold ideas deserve better odds.
heading
* https://www.acsh.org/news/2020/06/11/clinical-trial-success-rates-phase-and-therapeutic-area-14845
The intelligent advantage for early stage biopharma
emme connect offers robust price modeling capabilities that not only let you start your market sequencing and reimbursement strategies in your discovery phase but can even identify unmet needs and therapy gaps to inform potential new opportunities.
-
enhance operational efficiency
-
strengthen forecasting
-
inform discovery & pipeline
-
accelerate time to market
Schedule a meet & greet with emme connect today!
bottom of page